Millie
your market intelligence analyst
Search Results
505 results
Your search is now limited to «AstraZeneca» expert search.
MobiHealthNews 08/04/2020 13:40
Eko’s collaboration with AstraZeneca will allow us to expand the capability of our technology, generate real-world data, and explore disease management solutions while leveraging AstraZeneca’s global expertise and existing relationships across the treatment continuum for heart failure.
More from MobiHealthNews:
BioPharma-Reporter 08/04/2020 12:02
The two partners have built on an existing deal, made last month, which saw Emergent BioSolutions become AstraZeneca’s US contract manufacturer.
More from BioPharma-Reporter:
Contract Pharma 08/03/2020 09:40
Emergent BioSolutions Inc. has signed an agreement to provide contract development and manufacturing (CDMO) services for large-scale commercial drug substance manufacturing for AstraZeneca’s COVID-19 vaccine candidate, AZD1222.
More from Contract Pharma:
Updated Date: Mon, 03 Aug 2020 00:00:00 EDT.
More from National Library of Medicine - DailyMed Drug Label Updates (NLM):
PharmiWeb.com 07/31/2020 08:30
Pune, Maharashtra, India, July 31 2020 (Wiredrelease) MarketResearch.Biz –: The recent report posted via MarketResearch.Biz on Oral Biologics market offers critical market insights in conjunction with targeted segmentation evaluation. The report examines key using elements which might be anticipated to drive the increase of the market. Global Oral Biologics Market Research Report offers crucial data on numerous market situations, for example, ability improvement elements, elements controlling...
More from PharmiWeb.com:
Motley Fool 07/31/2020 07:01
Participants on this call may make forward-looking statements with respect to the operations and financial performance of AstraZeneca.
More from Motley Fool:
Financial Express (India) 07/31/2020 01:18
Pharmaceutical company AstraZeneca repeated its promise not to profit from a COVID-19 vaccine during the pandemic as it reported it was on track with late-stage trials for the treatment.
More from Financial Express (India):
Hindu Business Line (India) 07/31/2020 00:49
Pharmaceutical giant AstraZeneca, which is developing a vaccine against the novel coronavirus in collaboration with Oxford University, said that it has had “good data so far,” Hindustan Times reported.
More from Hindu Business Line (India):
LONDON (AP) — Pharmaceutical company AstraZeneca repeated its promise not to profit from a COVID-19 vaccine during the pandemic as it reported it was on track with late-stage trials for the treatment. Such promises were boosted by strong sales across its range of treatments during lockdown. Sales jumped by 14% to $12.6 billion in the […]
More from Seattle Times (United States):
Financial Post (Canada) 07/30/2020 12:03
Gloomy quarterly results from banks and a clutch of other firms saw the FTSE 100 post its worst session in five weeks on Thursday, while uncertainty about U.S. elections and a collapse in economic growth in the world’s largest economy also weighed. Global sentiment took a hit as a 32.9% plunge in U.S. second quarter […]
More from Financial Post (Canada):
Seeking Alpha 07/30/2020 11:19
The following slide deck was published by AstraZeneca PLC in conjunction with their 2020 Q2 earnings call.
More from Seeking Alpha:
Investor's Business Daily 07/30/2020 06:41
AstraZeneca reported adjusted earnings of 96 cents per share on $6.28 billion in sales for its second quarter.
More from Investor's Business Daily:
PMLiVE 07/30/2020 05:37
British drugmaker AstraZeneca escaped the negative impact of the COVID-19 pandemic in its second quarter results, posting an impressive increase in its revenues.
More from PMLiVE:
CNBC - Business 07/30/2020 05:37
A pedestrian walks past signage outside an AstraZeneca Plc research and development facility in Shanghai, China, on Monday, June 8, 2020.
More from CNBC - Business:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications